According to SP Tulsian of sptulsian.com, one shouldn't buy Suven Life Sciences at these levels. “One may prefer Wanbury or Bliss GVS Pharma from the same space,†he adds.
first published: Nov 12, 2013 04:16 pm
A collection of the most-viewed Moneycontrol videos.
Live: Sensex, Nifty extend surge to third day led by banking, IT stocks | Closing Bell
Tata Capital's Mega Rs 15,500 Cr IPO Kicks Off| Management On Future Outlook| IPO Watch Live
Live: Big IPOs, Q2 earnings season: Markets enter action-packed week | Opening Bell
The 23-Year-Old Struggling It Out As A Real Estate Broker | The Tenant
